Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 26;11(1):15155.
doi: 10.1038/s41598-021-94658-8.

Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004-2016

Affiliations

Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004-2016

Cheng Chen et al. Sci Rep. .

Abstract

Comprehensive investigations on the incidence and prognosis of pituitary tumors are still lacking. The present study aims to summarize the incidence, demographics, and survival outcome of pituitary adenoma on a population-based level. This study includes all pituitary adenomas reported in the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2016 in the United States. Extensive clinical and demographic characteristics were extracted and submitted to group comparisons. The standardized incidence rate was calculated and stratified by year at diagnosis, age/sex and age/treatment groups. The Kaplan-Meier analysis and multivariable regressions were performed to identify the factors associated with overall survival. A total of 47,180 pituitary tumors were identified, including 47,030 typical adenomas, 111 uncertain behavior pituitary adenomas, and 39 pituitary carcinomas. The overall standardized incidence rate was 4.8 cases per 100,000 person-years and the annual incidence rate continually trended upwards, with a peak seen in 2015. We noticed a bimodal age-related distribution in females and a unimodal distribution in males. In the multivariate regression analysis, the factors associated with prolonged survival included typical adenoma, younger age, and smaller tumor size. Whereas, black and male patients had worse overall survival. Our study provides a reliable estimate on the incidence of pituitary adenoma and confirms that the annual standardized incidence rate is increasing. Pituitary adenomas have a satisfactory long-term prognosis and age, tumor size, and tumor subtypes are related to overall survival. Though statistically significant, our inferential findings should be constrained within the limitations of SEER database.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Standardized incidence rate of primary pituitary adenoma by (a) year of diagnosis, (b) age/sex groups and (c) age/treatment groups. Reference population is the general US population or the population in corresponding groups.
Figure 2
Figure 2
Kaplan–Meier survival curves of all primary pituitary tumors stratified by (a) subtypes, (b) age groups and (c) tumor size. UPAs Uncertain behavior pituitary adenomas, PCs Pituitary carcinomas.

References

    1. Mete O, Cintosun A, Pressman I, Asa SL. Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod. Pathol. 2018;31:900–909. doi: 10.1038/s41379-018-0016-8. - DOI - PubMed
    1. Mehta GU, Lonser RR. Management of hormone-secreting pituitary adenomas. Neuro Oncol. 2017;19:762–773. doi: 10.1093/neuonc/now130. - DOI - PMC - PubMed
    1. Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS. Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary. 2011;14:276–283. doi: 10.1007/s11102-011-0308-1. - DOI - PubMed
    1. Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. 2011;96:632–642. doi: 10.1210/jc.2010-1942. - DOI - PubMed
    1. Tampourlou M, Fountas A, Ntali G, Karavitaki N. Mortality in patients with non-functioning pituitary adenoma. Pituitary. 2018;21:203–207. doi: 10.1007/s11102-018-0863-9. - DOI - PMC - PubMed

Publication types